EVOQ Therapeutics has received a $2 million grant from the National Institutes of Health (NIH) to advance novel therapies for autoimmune diseases. Dr James Moon, Chief Scientific Officer of EVOQ Therapeutics, said: "This support will enable us to accelerate the development of our platform, which we believe could offer significant breakthroughs in treating some of […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!